They first performed IHC on 155 pairs of NSCLC and adjacent normal tissue samples and showed that SMYD3 was significantly upregulated in NSCLC samples when compared to normal tissue samples [70]. Here, SMYD3 is linked to non-small cell lung carcinoma.